Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Technische Universität München - Klinikum Rechts Der Isar currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is localized in 1 distinct art unit and is being overseen by 1 distinct examiner. The portfolio shows a very concentrated effort within this specific technical domain. The institution's current prosecution efforts are entirely concentrated on this single matter, making the interaction with the assigned examiner the primary focus of its patent strategy.
The busiest examiner for the institution is DONOHUE, SEAN R, who is managing 1 pending office action. This single action constitutes the total pending workload for the organization. Navigating the 1 pending office action with this specific examiner is the current priority for the institution's prosecution strategy in Biotechnology & Pharmaceuticals. Success depends on addressing the specific feedback from this 1 distinct examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.4% | +21.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260272 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | DONOHUE, SEAN R | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260272 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | DONOHUE, SEAN R | 29d |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260272 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | DONOHUE, SEAN R | 1618 | §102§103Other | Final Rejection | 29d | Pending | Jul 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTechnische Universität München - Klinikum Rechts Der Isar has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Sean R Donohue has the most, with 1 of Technische Universität München - Klinikum Rechts Der Isar's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.